ESTA · Establishment Labs Holdings Inc.
Market Cap
$2.21B
Shares
29.80M
ESTA metrics
68 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$74.29
Market cap
$2.21B
Price action
19 metricsPrice change (1W)
+5.2%
Price change (30D)
-1.0%
Price change (3M)
0.0%
Price change (6M)
+5.5%
Price change (YTD)
+1.9%
Price change (1Y)
+92.1%
Trailing year
Price change (5Y)
-0.5%
52-week high
$95.65
52-week low
$36.84
Change from 52-week high
-22.3%
Change from 52-week low
+101.7%
Annualized volatility
55.2%
Beta
1.4
RSI (14D)
45.2
Price vs SMA 50
-11.0%
Price vs SMA 200
+1.3%
Avg volume (3M)
594,705
Relative volume
0.6
Average dollar volume
$50.22M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
29.80M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
9.0×
reciprocal yield 11.1%
P / book
102.5
reciprocal yield 1.0%
FCF yield
-1.9%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
7.5×
reciprocal yield 13.4%
EV / revenue historical average (5Y)
7.5×
reciprocal yield 13.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
70.5%
Operating margin
-7.6%
Trailing 12 months
Net margin
-15.8%
Gross profit (TTM)
$173.27M
Operating profit (TTM)
−$18.76M
Net income (TTM)
−$38.89M
Trailing 12 months
Diluted EPS (TTM)
$-1.29
FCF margin
-16.9%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+31.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$245.82M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.2%
Year over year · more shares
Revenue CAGR (3Y)
+9.3%
Revenue CAGR (5Y)
+20.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-180.0%
Return on assets
-11.1%
Debt / equity
—
Current ratio
3.8
EBITDA (TTM)
−$22.37M
Free cash flow (TTM)
−$41.51M
Quick ratio
2.5
Interest coverage
-0.7
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$71.16M
Total assets
$351.93M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$32.32M
Capital expenditures (TTM)
$9.18M
R&D (TTM)
$20.33M
SG&A (TTM)
$171.70M
Stock compensation (TTM)
$11.82M
R&D / revenue
8.3%
Stock compensation / revenue
4.8%
Ownership (13F)
3 metrics13F filers
199
13F filer change QoQ
+20
Institutional ownership
95.8%
Short interest
3 metricsShort interest
13.8%
Latest settlement · 5.9 days to cover
Days to cover
5.9d
Short-squeeze score
65 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1688757
CUSIP
G31249108
13F (30d)
141 filings
141 filers
Visit website
Investor relations